Literature DB >> 10556875

Improving biosensor analysis.

D G Myszka1.   

Abstract

The quality of optical biosensor data must be improved in order to characterize the mechanism and rate constants associated with molecular interactions. Many of the artifacts associated with binding data can be minimized or eliminated by designing the experiment properly, collecting data under optimum conditions and processing the data with reference surfaces. It is possible to globally fit high-quality biosensor data with simple bimolecular reaction models, which validates the technology as a biophysical tool for interaction analysis. Copyright 1999 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  1999        PMID: 10556875     DOI: 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  258 in total

1.  Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Authors:  E Leclerc; D Peretz; H Ball; H Sakurai; G Legname; A Serban; S B Prusiner; D R Burton; R A Williamson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors.

Authors:  T L Hoffman; G Canziani; L Jia; J Rucker; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Analysis of a preQ1-I riboswitch in effector-free and bound states reveals a metabolite-programmed nucleobase-stacking spine that controls gene regulation.

Authors:  Griffin M Schroeder; Debapratim Dutta; Chapin E Cavender; Jermaine L Jenkins; Elizabeth M Pritchett; Cameron D Baker; John M Ashton; David H Mathews; Joseph E Wedekind
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

4.  Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential.

Authors:  M S Lechner; G E Begg; D W Speicher; F J Rauscher
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Kinetic analysis of estrogen receptor/ligand interactions.

Authors:  Rebecca L Rich; Lise R Hoth; Kieran F Geoghegan; Thomas A Brown; Peter K LeMotte; Samuel P Simons; Preston Hensley; David G Myszka
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

6.  Surface plasmon resonance studies of the direct interaction between a drug/intestinal brush border membrane.

Authors:  Kwangmeyung Kim; Sungpil Cho; Jae Hyung Park; Youngro Byun; Hesson Chung; Ick Chan Kwon; Seo Young Jeong
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

7.  Building better fibrin knob mimics: an investigation of synthetic fibrin knob peptide structures in solution and their dynamic binding with fibrinogen/fibrin holes.

Authors:  Sarah E Stabenfeldt; J Jared Gossett; Thomas H Barker
Journal:  Blood       Date:  2010-05-18       Impact factor: 22.113

8.  Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.

Authors:  Sai Duriseti; David H Goetz; Daniel R Hostetter; Aaron M LeBeau; Ying Wei; Charles S Craik
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

9.  PrgB promotes aggregation, biofilm formation, and conjugation through DNA binding and compaction.

Authors:  Andreas Schmitt; Kai Jiang; Martha I Camacho; Venkateswara Rao Jonna; Anders Hofer; Fredrik Westerlund; Peter J Christie; Ronnie P-A Berntsson
Journal:  Mol Microbiol       Date:  2018-07-31       Impact factor: 3.501

10.  Structure and mechanism of the phage T4 recombination mediator protein UvsY.

Authors:  Stefan Gajewski; Michael Brett Waddell; Sivaraja Vaithiyalingam; Amanda Nourse; Zhenmei Li; Nils Woetzel; Nathan Alexander; Jens Meiler; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.